IR@PKUHSC  > 北京大学第二临床医学院  > 血液科
学科主题临床医学
Graft-versus-leukemia effects of Wilms′ tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Wang Zhi-dong; Li Dan; Huang Xiao-jun
关键词Cytotoxic t Cells Wilms&Prime Tumor 1 Protein Graft-versus-leukemia Effects Chronic Myeloid Leukemia Allogeneic Hematopoietic Stem Cell Transplantation
刊名CHINESE MEDICAL JOURNAL
2010-04-05
DOI10.3760/cma.j.issn.0366-6999.2010.07.027
123期:7页:912-916
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]RESIDUAL DISEASE ; RESPONSES ; MEMORY ; WT1 ; EXPRESSION ; PRODUCT ; TRIAL ; CD57
英文摘要

Background The role of Wilms′ tumor 1 protein (WT1)-specific cytotoxic T cells (CTL) in eradicating chronic myeloid leukemia (CML) cells is to be established. The aim of this study was to determine whether WT1 contributed to the graft-versus-leukemia effects (GVLE) for CML following allogeneic hematopoietic stem cell transplantation (HSCT).

Methods High-resolution human leukocyte antigen (HLA) class I genotyping was performed by sequence-specific polymerase chain reaction (PCR). Fifteen HLA-A*2402 patients with CML who underwent allogeneic HSCT were enrolled in this study. We monitored the frequency of WT1-specific CTL by pentamer assay and the molecular minimal residual disease by real-time quantitative PCR.

Results A CD8(+) T-cell response to WT1 was observed in 14 of 15 patients after HSCT. The median frequencies of WT1-CTL were 0.54%, 0.62%, 0.81% and 1.28% (%CD8) on days 30, 60, 90 and 180, respectively. The median frequency of WT1-CTL (1.38%) in patients with molecular remission (MoR) was significantly higher than that in those without MoR (0.38%) on day 30, while no significant differences between them were detected on days 60, 90 and 180. The increase of WT1-CTL was associated with a decrease in bcr-abl expression and MoR; and the decrease of WT1-CTL was associated with an increase in bcr-abl expression, suggesting a WT1-driven GVL effect. WT1-CTL had a predominant effector-memory phenotype (CD45RO(+)CD27(-)CD57(+)).

Conclusions The emergence of WT1-CTL with an effector-memory phenotype is associated with GVLE in CML patients after HSCT. This will pave the way for the WT1 vaccines to enhance GVLE after HSCT in CML. Chin Med J 2010;123(7):912-916

语种英语
WOS记录号WOS:000276683700027
项目编号30725038 ; IRT0702 ; 2006AA02Z4A0 ; 20060001108
资助机构Natural Science Foundation ; National 863 Hi-tech Project ; Invocation Team Fund ; Ministry of Education of China
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/57956
专题北京大学第二临床医学院_血液科
作者单位Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Wang Zhi-dong,Li Dan,Huang Xiao-jun. Graft-versus-leukemia effects of Wilms′ tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation[J]. CHINESE MEDICAL JOURNAL,2010,123(7):912-916.
APA Wang Zhi-dong,Li Dan,&Huang Xiao-jun.(2010).Graft-versus-leukemia effects of Wilms′ tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.CHINESE MEDICAL JOURNAL,123(7),912-916.
MLA Wang Zhi-dong,et al."Graft-versus-leukemia effects of Wilms′ tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation".CHINESE MEDICAL JOURNAL 123.7(2010):912-916.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang Zhi-dong]的文章
[Li Dan]的文章
[Huang Xiao-jun]的文章
百度学术
百度学术中相似的文章
[Wang Zhi-dong]的文章
[Li Dan]的文章
[Huang Xiao-jun]的文章
必应学术
必应学术中相似的文章
[Wang Zhi-dong]的文章
[Li Dan]的文章
[Huang Xiao-jun]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。